This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Rite Aid Gets FTC Nod for Sale of Fewer Stores to Walgreens
by Zacks Equity Research
After four amendments, Rite Aid Corp. (RAD) and Walgreens Boots Alliance Inc. (WBA) finally received a nod for the fresh proposal the latter put forward yesterday.
Walgreens to Revisit Rite Aid Deal for Antitrust Approval
by Zacks Equity Research
The Federal Trade Commission ("FTC") seems to be getting harsher on drugstore chains Walgreens Boots Alliance Inc. (WBA) and Rite Aid Corp. (RAD), which have been trying to appease the regulatory body since its initial merger pact in 2015.
Options Traders Expect Huge Moves in Herbalife (HLF) Stock
by Zacks Equity Research
Investors in Herbalife (HLF) need to pay close attention to the stock based on moves in the options market lately.
Is Herbalife (HLF) a Great Stock for Value Investors?
by Zacks Equity Research
Let's see if Herbalife Ltd. (HLF) stock is a good choice for value-oriented investors right now from multiple angles.
Herbalife (HLF) Catches Eye: Stock Jumps 9.8%
by Zacks Equity Research
Herbalife Ltd. (HLF) was a big mover last session, as the company saw its shares rise over 9% on the day.
Here's Why Herbalife (HLF) Stock Jumped Today
by Megan Sanks
Shares of Herbalife (HLF) popped 11% in morning trading on Monday after the company said that it held talks to go private last week, but discussions ended without a deal.
Implied Volatility Surging for Herbalife (HLF) Stock Options
by Zacks Equity Research
Herbalife (HLF) warrants investors' attention based on moves in the options market lately.
Are Options Traders Betting on a Big Move in Herbalife (HLF) Stock?
by Zacks Equity Research
Herbalife (HLF) warrants investors' attention based on moves in the options market lately.
Can Herbalife (HLF) Keep the Earnings Streak Alive in Q2?
by Zacks Equity Research
Though Herbalife Ltd. (HLF) raised its earnings guidance for the second quarter, it expects sales and volumes to decline due to the new tougher Federal Trade Commission rules in the U.S.
Have You Noticed Potential in Herbalife? Stock Adds 48% YTD
by Zacks Equity Research
Shares of Herbalife (HLF) have exhibited a bullish run on the index.
Implied Volatility Surging for Herbalife (HLF) Stock Options
by Zacks Equity Research
Investors in Herbalife (HLF) need to pay close attention to the stock based on moves in the options market lately.
Here's Why Herbalife Ltd. (HLF) Stock Fell Today
by Benjamin Rains
Shares of Herbalife Ltd. (HLF) dropped 7.24% on Monday after the weight management and nutritional supplement company cut its sales guidance for the current quarter.
Are Options Traders Betting on a Big Move in Herbalife (HLF) Stock?
by Zacks Equity Research
Investors in Herbalife Ltd. (HLF) need to pay close attention to the stock based on moves in the options market lately.
Herbalife (HLF) Stock Up on Better-than-Expected Q1 Earnings
by Zacks Equity Research
Shares of Herbalife Ltd. (HLF) gained 4.5% in after-hours trading on May 4 after the nutritional-products company posted better-than-expected earnings and revenues in the first quarter 2017 and issued an upbeat 2017 outlook.
Can Herbalife (HLF) Spring a Surprise This Earnings Season?
by Zacks Equity Research
Herbalife Ltd (HLF) is set to report first-quarter 2017 results on May 4.
Implied Volatility Surging for Herbalife (HLF) Stock Options
by Zacks Equity Research
Herbalife (HLF) warrants investors' attention based on moves in the options market lately.
Herbalife (HLF) Shares Move Up on Carl Icahn's Announcement
by Zacks Equity Research
Shares of Herbalife Ltd. (HLF) has rallied more than 3% since Mar 13 after activist investor Carl Icahn announced that he has raised his stake in the company.
Why Herbalife (HLF) Q4 Earnings Failed to Impress Investors
by Zacks Equity Research
Shares of Herbalife Ltd. (HLF) fell 4.51% after the nutritional-products company issued a weak 2017 outlook in the extended session on Feb 23. Despite posting better-than-expected earnings in fourth-quarter 2016, sales missed the consensus mark due to currency headwinds and lower volumes.
What's in Store for Herbalife (HLF) this Earnings Season?
by Zacks Equity Research
Herbalife Ltd (HLF) is set to report fourth-quarter 2016 results on Feb 23. The question lingering in investors' minds is, whether the company will be able to maintain its positive earnings surprise streak in the to-be-reported quarter.
Nu Skin (NUS) Q4 Earnings: Disappointment in the Cards? (revised)
by Zacks Equity Research
Despite the positives, the company faces several regulatory issues.
Nu Skin (NUS) Q4 Earnings: Disappointment in the Cards?
by Zacks Equity Research
Nu-Skin Enterprises, Inc. (NUS) is set to report fourth-quarter 2016 results on Feb 13, after the market closes. The question lingering in investors' minds is, whether the company will be able to deliver a positive earnings surprise in the to-be-reported quarter.
New Strong Sell Stocks for January 5th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Thursday
Inside the Mind of Bill Ackman As Valeant Collapsed
by Kevin Cook
How one of the smartest minds on Wall Street was blinded by belief and abandoned due diligence.
Bear of the Day: GNC (GNC)
by David Bartosiak
GNC is having problems pumping up the profits
Bull of the Day: Herbalife (HLF)
by Neena Mishra
Did Icahn win the battle with Ackman over Herbalife?